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Enterotoxigenic Escherichia coIi(ETEC), a common cause of diarrhea among children in 
developing countries and in travelers, adheres to human small intestine via colonization 
factors (CFs) and secretes enterotoxins. Eight genetically related Class 5 fimbriae are 
prevalent ETEC CFs. Each is composed of a single tip-localized adhesin attached to a stalk of 
repeating major subunits. In this study, we performed epitope mapping and functional 
activity of total 28 monodonal antibodies (MAbs) against CfaE, CsbD and CotD, the tip 
adhesins of CFA/l, CS17 and CS2 fimbriae,.respectively. To assess the MAb epitopes, panels 
of existing MAbs specific for each adhesin were tested for reactivity to the homologous 
adhesins, natural allelic variants and mutants by dot blot analysis and ELISA. Five anti-
dscCfaE MAbs reacting to the CfaE adhesin domain, specifically recognized residues R67 and 
11181, which are key residues in the receptor-binding pocket. Three anti-dscCsbD MAbs 
recognized residues 185, H144 or R181, all localized to the upper pole of CsbD. None of anti-
dscCotD MAbs revealed specific epitope regions. We also tested the MAb reactivity to the 
heterologous Class 5 adhesins. The observed patterns of MAb cross-reactivity Included 
(1) exclusive reactivity to the homologous adheslns, (2) subclass-specific cross-reactivity, 
(3) class-specific cross-reactivity, and (4) selective cross-reactivity to certain heterologous 
adhesins. The MAb functional activity was measured in the minimum MAb concentration to 
inhibit hemagglutination of bovine erythrocytes by ETEC strains. Generally, lower MAb 
inhibition concentration correlates to higher MAb reactivity to the corresponding adhesin. 
However, the high ELISA reactivity of MAbs was not indicative to the functionality. Three 
MAbs showed class-wide reactivity, but none of the 28 MAbs showed class-wide 
hemagglutination inhibition. Collectively, our findings were the first step of fine epitope 
mapping of MAbs to the three representative Class S adhesins, and suggested diverse 
epitopes with unique MAb functionality on the three ETEC adhesins. 
Enterotoxigenie Escherichia coli (ETEC) can cause diarrhea in children in underdeveloped 
countries and in travelers, and lead to fatality among affected children. ETEC attaches to and 
colonizes human small intestinal cells via fimbrial structures called colonization factors, and 
subsequently releases enterotoxins that induce fluid secretion. Class 5 fimbriae, the largest 
class of human-specific ETEC colonization factors, include eight members namely CFA/I, 
CS 1, CS2, CS4, CSI4, CS17, CS 19 and PCF071 1 . Colonization factor antigen I (CFA/1) is the 
prototype of Class 5 fimbriae and the most prevalent colonization factor in ETEC causing 
diarrhea. CFA/1 fimbriae are composed of stalk-forming major pilin subunit CfaB, and a tip- 
localized, minor adhesin subunitCfaE 1 , assembled via donor strand complementation2. 
Based on sequence similarity, Class 5 fimbriae are divided to three subclasses, 5a 
(CPA/I, CS4 and CS14), Sb (CS1, CSI 7, CS19 and PCF071) and 5c (CS2) (Fig. 1). The minor 
adhesion subunits within subclasses are more conserved than the major subunits. Among 
subclass 5a, CfaE (CPA/I adhesin), CsfD (CS4 adhesin) and CsuD (CS 14 adhesin) share > 
80% sequence identity. CshD (CS 17 adhesin) and CooD (CS1 adhesin) in subclass 5b share 
97% sequence identity. In comparison, the major subunits shows only 50% identity among 
subclasses 5a and Sb.
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fimbriae
CfaE (CFA/ladhesin)	 Figure 1 The phylogenetic tree of 
COD (CS4adhesn) 	 ETEC Class 5 fimbrial adhesins. 
CsuD (CS14adhesln) 	 Class 5 fimbriae are divided to 
ooL) (CS1 adhesin) 	 three subclasses (5a, Sb and Sc). 
Cost) (PCF071 adhesin)	 Length	 of branch	 indicates CsdD (CS19 adhesin) 	
evolutionary distance between 
sbD (Cs17 adhesin)
the adhesins. CoW (CS2 adhesin) 
The minor subunits are important in ETEC adhesion to host cells. Recent reports show 
that two arginyl residues conserved in Class 5 adhesins are crucial in the attachment of ME, 
both residues are located in the receptor-binding pocket. Substitution of alanine for residue 
R181 in CfaE and Cool) abolished agglutination of bovine erythrocytes, signifying the 
importance of this residue in bacterial adherence 3 . R67 is another conserved residue shown to 
be critical in attachment4. Presence of these strong positively charged residues at the binding 
pocket attracts molecules of opposite charge, suggested to be sialylated glycoproteins 5 '6 . Aside 
from site-directed mutagenesis, naturally , occurring mutations that are acquired under positive 
selection are also clues to predict the residues needed for receptor binding. Three natural 
allotypic variants of ME, each carries a single amino acid change from referent strain CFAII 
1110407, namely T911, Al28V and Q142R, all spatially located on loops around CfaE 
receptor-binding pocket. Using CfaE as structural homologue, CsbD also maps several amino 
acid changes clustering around putative receptor-binding sites. CFAII and CS17 fimbriae 
harboring the CfaE and CsbD variants, show higher binding to erythrocytes under increasing 
shear conditions7, so the residue changes are suggested to enhance attachment to intestinal 
epithelial surface. 
Discoveries of these residues involved in receptor binding can be useful in vaccine 
development to prevent ETEC causing infection. Another approach to do so is to examine 
epitope regions on the flmbriae by using monoclonal antibodies (MAbs) technology. Previous 
studies have presented that native Class 5 fimbriae display immunological cross-reactivity8'9. 
Specifically, the major subunits are reported to share some cross-reactive epitopes 3. However, 
little is known about common epitopes of Class 5 adhesins. Understanding the protein structure 
offers spatial details in examining the epitope regions. Crystal structure of recombinant CfaE 
termeddonor-strand-complemented CfaE (dscCfaE)'° has been reported. The dscCfaE contains 
an in cis C-terminal extension comprising of a linker peptide and nineteen N-terminal residues 
donated from major subunit CfaB, in which the extension helps the proper folding and 
stabilization of CfaE as a soluble monomer2. The crystal structure of dscCfaE reveals that this 
molecule forms a cylinder shape with an adhesin domain (CfaEad) and a pilin domain 
(CfaEpd)4. The adhesin domain holds the putative binding pocket at the upper pole of the 
molecule, while the pilin domain links the minor subunit with the major subunit. 
Studies have been done to determine neutralizing epitopes on CFAII adhesin by using 
monoclonal antibodies raised against dsçCfaE 10. Nevertheless, fine epitope mapping and cross 
reactivity of MAbs to heterologous Class 5 adhesins have not been investigated. In the current 
study, we studied the reactivity of three panels of MAbs: anti-dscCfaE, anti-dscCsbD, and anti-
dscCotD .MAbs, to various Class 5 representative adhesins including allelic variants and 
mutants, and the functional activity of MAbs in terms of hemagglutination inhibition. The 
results provided basis for fine epitope mapping of these MAbs and revealed the relationship 
between cross-reactivity and functional activity of the MAbs in inhibiting bacterial adherence.
METHODS 
Antibody resources. MAbs specific for dscCfaE (n = 9), dscCsbD (n = 11) and dscCotD 
(n 8) were generated and purified from hybridoma cell culture at NAMRU-3, Cairo, 
Egypt10.The hybridoma, MAb supernatants and purified MAbs were maintained at the Naval 
Medical Research Center (NMRC), MD. 
In this study, two anti-dscCfaE MAbs and eight anti-dscCotD MAbs were purified from 
cell culture supernatants by affinity chromatography in a 0.5 ml column packed with Protein G 
resin (Gen Script). Lyophilized culture supernatants were resuspended in IX PBS, pH 7.4 and 
loaded onto the Protein G column at a flow rate of 1 ml/min. The column was washed with lx 
PBS, pH 7.4 and eluted with 0.1 M glycine, OR 2.5. The eluates were immediately neutralized 
with 1 M Tris, pH 8.5 and analyzed on SDS-PAGE. The pure fractions were pooled and 
dialyzed against water. After lyophilization for 24-48 h, antibodies were resuspended in 1X 
PBS, p11 7.4 and the MAb concentration was determined using a BCA protein assay kit 
(Pierce). The purity of MAbs was inspected in SDS-PAGE. 
Overexpression and purification of dscCfaE allelic proteins. Three dscCfaE allelic variants 
(dscCfaE/T911, dscCfaE/Al28V and dscCfaE/Q142R) were generated via site-directed 
mutagenesis (QuikChange, Stratagene) using the pET24a-dscl9CfaEHJ0407-6xllis plasmid as 
template. The recombinant plasmids were transformed into BL2 I -DE3 strain for expression. 
APS media containing 50 ig/ml kananiycin and 4 g/l glycerol or glucose were inoculated with 
overnight cultures of the allelic variants, and incubated at 32 °C in shake flasks. When the 
0D6® reached 0.6-0.8, the media were induced with 1 mM IPTG and incubated for 3 h until 
harvesting. 
The cells were homogenized in 1X PBS, pH 7.4 and lysed using microfluidizer. After 
centrifugation, the supernatants were filtered and loaded onto a nickel-affinity column (5 ml 
HisTrap FF crude, GE Healthcare) at a flow rate of 5 ml/min. Fractions containing target 
proteins were pooled, diluted in 20 mM phosphate, pH 6.5 and loaded onto a cation-exchange 
column (5 ml HiTrap SP HP, GE Healthcare). The dscCfaE allelic proteins were eluted by a 
linear gradient to 1 M NaC1 over 30 column volumes, and purity was analyzed on SDS-PAGE. 
Purified fractions were then pooled and concentrated by using Amicon Ultra centrifugal filter 
with 10 kD cut-off (Millipore). 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot. For SDS-PAGE, 
1-5 j.tg of purified CfaE allelic variants or dscCsbD proteins were mixed with reducing agent 
(0-mercaptoethanol), denatured at 85 C and separated on 15% SDS-PAGE. The protein gels 
were stained with GelCode Blue reagent (Thermo Scientific) for 2 h, and destained with water 
overnight. 
For Western blot, the proteins on SDS-PAGE gels were transferred onto nitrocellulose 
membrane. Membranes were agitated in a 1:1,000 dilution of anti-dscCfaE or anti-dscCsbD 
MAbs in blocking solution (2% skim milk (Difco, BD) in TBS, 0.05% Tween 20 (TBS-T)) at 
4 °C overnight. After washing with water, membranes were incubated in a 1:3,000 dilution of 
AP-conjugated goat anti-mouse IgG (BioRad) in blocking solution for 2 h at room temperature. 
Membranes were incubated in AP developing solution containing Nfl and BCIP on a shaker 
for 5 min until protein bands became visible.
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Protein dot blot. Reactivity of three anti-adhesin MAb panels to the following antigens was 
analyzed on dot blot. The antigens included adhesins in subclass 5a (dscCfaE and its allelic 
variants and mutants, dscCsfD and dscCsuD), adhesins in subclass 5b (dscCsbD and its allelic 
variants and mutants, and dscCooD) and adhesin in subclass 5c (dscCotD) (see Tables 1 and 
2). The adhesin domains of CfaE, CsbD, or CotD (designated CfaEád, CsbDad, or CotDad, 
respectively) were included on the blot to define the MAb domain specificity. Native 
dscCfaEH,0407, dscCsbDws67$SA and dscCotD (representatives from subclasses 5a, 5b and 5c, 
respectively) were used as positive control and indicator of conformational epitope, while heat-
denatured proteins served as indicator of linear epitope. 
Two micrograms of each antigen was diluted in 1X PBS, pH 7.4 and blotted on 
nitrocellulose membrane for 1 h. For chemiluminescent method, the antigens on membrane 
were incubated with anti-dscCfaE MAbs (2 jig/ml) diluted in 2% skim milk or BSA in TBS-T, 
at 4 C overnight and then incubated in a 1:30,000 dilution of FIRP-coupled goat anti-mouse 
IgG (Jackson ImmunoResearch) for 2 h. The signals were detected by using SuperSignal West 
Femto Maximum Sensitivity Substrate kit (Pierce). Use of BSA as blocking reagent produced 
clearer signals of the antigens than skim milk. Milk contains abundant proteins with large 
molecular mass, and is less sensitive to detect protein at low concentration". Although 
chemiluminescent detection uses less primary and secondary antibodies, this method could not 
detect weak signal of CfaE peptides. We also noticed a pattern of light specks and black spots 
on membranes that hampered with signal reading, so we changed to colorimetric detection. 
For colorimetric method, the blotted antigens on membrane were incubated with anti-
adhesin MAbs (2jig/nil) diluted in 2% BSA (Sigma) in TBS-T by agitation for 16-18 h at 4 
C, followed by incubation with a 1:3,000 dilution of AP-conjugated anti-mouse IgG (BioRad) 
for 2 h at room temperature. The protein signals were developed as described in Western blot 
protocol. The signal intensity was analyzed at a BioRad image Station. 
Table 1 List of dscCfaE and dscCsbD mutants made to assist in fine epitOpe mapping of anti-
adhesin MAbs.
Adhesin Mutant protein name 
(designated in this report)  
Region of mutation Source 
CfaE
dscfaE/R67A Receptor binding domain NMRC collection 
dscCfaE/R181A Receptor binding domain NMRC collection 
dscCfaE/R182A Receptor binding domain NMRC collection 
CsbD dscCsbDfT84N-L85R Near receptor binding domain NMRC collection 
dscCsbD/H144A-Y145N Near receptor binding domain NMRC collection
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Table 2 List of natural allotypic variants of CfaE and CsbD from wild type ETEC strains. CotD 
has no variant. 
Adhesin Variant type Allelic residue Region of allelic Protein name Source 
strain difference difference (designated in this 
report)  
CfaE H10407 Referent - dscCfaEH107 NMRC collection 
(CFA/l)  strain  
101`2 1911 Near receptor dscCfaE/T911 In this study 
binding domain  
W54437A-1 Al28V Near receptor dscCfaE/Al28V In this study 
binding domain  
SMJ344 Q142R Near receptor dscCfaE/Q142R In this study 
binding domain  
CsbD WS6788A Referent - dscCsbDws67gm NMRC collection 
(CS17)  strain  
15NO2- L851, H144A Near receptor dscCsbbNl39 NMRC collection 
013966/A3 binding domain  
WS4240A 1851 Near receptor N/A NMRC collection 
binding domain  
E20738 N62S, S74T, Near upper pole of dscCsbD 0738 NMRC collection 
T84N, L85R, adhesin domain, 
H144A, Y145N, except for Y293H 
Y293Hb  
CotD C91f Invariant - dscCotD NMRC collection 
(CS2)
3 Abbreviated strain ID = CS17 I.5N139 
b Modification site is located in pilin domain of CsbD 
Protein enzyme-linked iinmunosorbent assay (ELISA). Selected fimbrial adhesins from 
subclasses 5a, 5b and Sc were coated at a concentration of 2 pg/mi in 1X PBS, pH 7.4 on an 
ELISA plate (NUNC, Thermo Scientific) at 37 °C for 1 h, following by washing with IX PBS, 
pH 7.4 three times. The plate was blocked with 5% (v/v) fetal bovine serum (FBS) in 1X PBS, 
pH 7.4 at 37 °C for 1 h, and washed with 1X PBS (pH 7.4), 0.05% Tween 20 (PBS-I). The 
plate was incubated for 1 h at 37 °C with anti-adhesin MAbs (diluted to 2-4 jig/ml in 1X PBS, 
pH 7.4). The MAb concentration used in this assay was determined by the MAb titer which 
gave high ELISA reactivity to representative proteins from each subclass at a plateau of 
saturation, preceding a titer that led to a decline in reactivity (data not shown). Bound 
antibodies were detected by incubation for 2 h with HRP-conjugated goat anti-mouse IgG 
(Jackson ImmunoResearch) at 1:1,000 dilution in 5% FBS in IX PBS, pH 7.4. The assay was 
developed for 20 min at room temperature with fresh o-phenylenediamine (OPD) solution 
prepared by dissolving 30 mg of OPD-dihydrochloride (Sigma) in 30 ml of 0.1 M sodium 
citrate (pH 4.5) and 12 p1 of 30% H202, and the OD signals were read at 450 tim. 
CfaE peptide ELISA. A peptide library of CfaE containing 71 CfaE oligopeptides (15-mers) 
with five overlapping residues in each consecutive peptide was obtained from GenScript. Each 
peptide (2 pg/mI in sodium carbonate buffer, pH 9.9) was coated on an ELISA plate (NUNC, 
Thermo Scientific) and incubated overnight at 4 °C. The plate was washed with 1X PBS, pH 
7.4 after each incubation. Subsequent incubations were performed at 37 °C. After blocking for 
1 h with 1% (w/v) ESA in 1X PBS (pH 7.4), the plate was incubated with anti-dscCfaE MAb 
P6C1 1 diluted to 2 1g/ml in 1X PBS, pH 7.4 for 1 h, followed by incubation for 2 h with HRP-
conjugated goat anti-mouse IgG (Jackson ImmunoResearch) at a 1:1,000 dilution. The 
substrate of HRP was added as described for protein ELISA analysis. 
Multiple sequence alignment—assisted epitope mapping of anti-adhesin MAbs. Sequences 
from six tested adhesins (CfaE, Csf), CsuD, CsbD, CooD and CotD) was aligned using 
BioEdit and ClustaiW programs. Based on the cross-reactivity patterns on ELISA and dot blot, 
identical and non-identical residues on heterologous adhesins were grouped and compared for 
potential epitopes of the MAbs. 
Mannose-resistant hemagglutination and hemagglutination inhibition assays. ETEC 
strains CS! WS1974A, CS14 WS3294A, CS17 LSN139 and CS17 WS6788A were plated on 
CFA agar supplemented with 1.5 g/l bile salts (Difco, BD) and ETEC strains CFA/j H10407, 
CS2 C91f and CS4 BANG] 0-SP were grown overnight on CFA agar at 37°C. Addition of bile 
salt is required for fimbriae formation for selective Class 5 fimbriae' 2 . Confluent bacterial lawn 
was resuspended in 1X PBS (pH 7.4), 0,5% D-rnannose (PBS-M) until reaching an 0D 650 of 
40 ± 5%. Two-fold serial dilutions of bacterial suspensions were prepared in PBS-M. To 
prepare erythrocytes, bovine red blood cells (RBCs) (Lampire Biological Lab) were washed in 
IX PBS, pH 7.4 three times, and resuspended to a final concentration of 3% in PBS-M. 
For mannose-resistant hemagglutination (MRFIA) assay, 25 pJ of the following 
components (serially diluted bacterial suspensions, PBS-M and 3% RBCs) were mixed in 12-
well ceramic plates, followed by incubation on a waver platform on ice for 20 mm. One well 
lacking bacterial suspension served as negative control. The plates were then visually inspected 
and scored for MRHA activity showing either presence or absence of agglutination of blood 
cells. The lowest dilution of bacterial suspensions that induced hemagglutination determined 
the minimal hemagglutination titer (MIHT). 
For hemagglutination inhibition (HA!) assay, each anti-adhesin MAb was serially 
diluted in PBS-M., and 25 pl of the diluted MAb was mixed with an equal amount of bacterial 
suspension at a dilution of 2-4X MHT and gently rocked in ceramic plates for 20 min at room 
temperature. After adding 3% RBCs, the plates were rocked on ice for 20 mm. One well 
without MAb served as positive control for MRHA. HAl titer was expressed as the lowest 
dilution of antibody that inhibited agglutination of blood cells. 
Microbead-based hemagglutination assay. One hundred microliters of polystyrene 
microbeads (Polysclences, Inc.) were washed with 1X PBS, pH 7.4 three times, and bead pellet 
was resuspended in 1X PBS, pH 7.4. Fifty micrograms of protein was mixed with the bead 
suspension and vortexed at room temperature for I h. After centrifugation, the protein/bead 
mixture was blocked with BSA (50 tg/ml) in lx PBS, pH 7.4 and agitated twice for 30 mm, 
followed by resuspension into PBS-M. Then, protein/bead suspension was mixed with 3% 
RBCs and incubated on ice, as described in MRHA analysis.
RESULTS 
Purification and functional characterization of dscCfaE allelic variants 
Following purification, three dscCfaE allelic variants were analyzed on SDS-PAGE and 
Western blot. All three proteins showed> 92% purity based on densitometry (data not shown) 
and gave a size of 40-41 kD (Fig. 2a,b). The protein identities were confirmed by anti-
dscCfaE polyclonal antibody and anti-histidine tag antibody (Fig. 2b). Based on the elution 
profile (Fig. 2c), dscCfaE/T91I and dscCfaE/Al28V were eluted out at similar salt gradient, 
while dscCfae/Q 1 42R was eluted at higher salt gradient. The allelic proteins also showed 
different peak intensities. dscCfaE/T9 II was purified from three liters of culture using glycerol 
as the carbon source, showing very low peak intensity as compared to dscCfaE/Al28V (from 
five liters) and dscCfaE/Q142R (from six liters) purified from culture in presence of glucose. 
Protein yield of dscCfaE/T911 was the lowest (0.07 mg/g cell paste), which is approximately 
33% of the yield of dscCfaE/Al28V (0.21 mg/g cell paste). This result suggested that glucose 
promoted higher protein expression than glycerol. 
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Figure 2 Assessment of purity 
of dscCfaE allelic variants 
after purification, reactivity 
by Western blot, and elution 
profiles from cation-
exchange chromatography. 
(a) dscCfaE variant proteins 
were denatured, run on 15% 
SDS-PAGE gel and stained 
with GelCode Blue reagent. 
(b) Immunoblotting of three 
dscCfaE	 allelic	 variant 
proteins. Anti-dscCfaE 
antibody and anti-histidine 
tag antibody were used as 
primary	 antibodies	 for 
protein detection. (c) 
Proteins were eluted in a 
linear gradient to 20 mM 
phosphate buffer (pH 6.5) 
with 1 M NaCI. Peaks of 
dscCfaE/T911, dscCfaE/Al28V 
and dscCfaE/Q142R 
corresponded to elution at 
13%, 14%, and 19% NaCl, 
respectively. Peak intensity is 
represented by the left y-axis 
and	 NaCl	 gradient	 is
indicated in the right y-axis. 
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The function of the dscCfaE variant proteins was tested in hemagglutination assay by 
adsorbing the purified adhesin variants to polystyrene microbeads that served as "bacteria-like" 
environment. Both dscCfaE/Al28V and dscCfaE/Q142R induced hemagglutination of bovine 
erythrocytes similarly as the positive control (dscCfaE), while dscCfaE/T911 did not 
agglutinate blood cells (Fig. 3). 
dscCfaE/T91t 	 dscCfE/Al2EV	 dscCfaE/Q142R	 ESA	 - 
•	
.1	 -p 
Figure 3 MRHA of dscCfaE allelic variants when protein-coated microbeads were incubated 
with bovine erythrocytes. Beads coated with dscCfaE showed hemagglutination (positive 
MRHA), and BSA-coated beads did not show hemagglutination (negative MRHA). For 
dscCfaE/T911-coated beads, no hemagglutination was observed, while both beads adsorbed 
with dscCfaE/Al28V and dscCfaE/Q142R exhibited positive MRHA. The assay was performed 
in duplicates. 
Domain specificity and epitope mapping by reactivity to homologous adhesins and mutants 
We determined the domain specificity of MAbs by ELISA reactivity to adhesins and mutants. 
Five anti-dscCfaE MAbs (P5C7, P6CI I, P6H4, P81310 and P1OA7) displayed moderate or 
high reactivity to CfaEad. Meanwhile, remaining four MAbs (P1F9, P2E11, P3B2 and P13A7) 
showed lack of reactivity to CfaEad, suggesting the four MAbs bind to CfaE pilin domain. Out 
of eleven anti-dscCsbD MAbs, nine of them (P1F7, P7C2, P9A5, P2A9, P6G1, P2H6, P9E1 1, 
P7F9 and P5Al2) reacted to CsbDad, while P91312 and P717I2 did not react to CsbDad. For 
anti-dscCotD MAbs, five MAbs (P3D1 1, P3F4, P7F6, P6B8 and P9A1O) reacted to adhesin 
domain, but not the other three MAbs (P2B8, P9G7 and P12A2). To summarize, 19 out of 28 
MAbs showed specificities to adhesin domains, indicating that the adhesin domain is slightly 
more immunogenic than the pilin domain, given that the receptor-binding pocket is located in 
the adhesin domain. 
Assessing reactivity to mutant proteins also contributed in determining potential epitopes 
for the MAbs. All anti-dscCfaE MAbs reacting to CfaEad, showed lack of reactivity to 
dscCfaE/R67A and dscCfaE/RI81A mutants. This result indicated that these MAbs recognized 
R67 and RI 81, as epitope residues (Table 3). Most anti-dscCsb.D MAbs and all anti-dscCotD 
MAbs did not show reactivity to dscCfaE, as well as to dscCfaE/R67A and dscCfaE/R181A 
mutants. Anti-dscCsbD MAb P7F9 was an exception; this MAb showed high reactivity to both 
dscCfaE and dscCfaE/R67A, that is equivalent to dscCsbDws67 8gA, but did not react to 
dscCfaE/R1 8 1A. This result indicated that MAb P7179 actually bind similarly to both CfaE and 
CsbD, and included R181 as its epitope, but not R67. 
In addition, anti-dscCsbD MAb P2H6 did not react to dscCsbDE20738 and 
dscCsbD/T84N-L85R, but gave high reactivity to dSCCSbD LSNI39 and dscCsbDIHl44A-Y145N 
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(data not shown). On the other hand, anti-dscCsbD MAb P1F7 did not react to dscCsbDE20738, 
dscCsbDLsNJ39 and dscCsbDfH144A-Y145N, but showed high reactivity to dscCsbD/T84N-
L85R (data not shown). Given that dscCsbD E20738
 contained multiple mutations (see Table 2), 
we suggested that MAb P2116 recognized T84 and L85, while MAb PIF7 recognized H144 
and Y145. 
Cross-reactivity of anti-adhesin MAbsto heterologous adhesins 
Based on ELTSA and dot blot, we observed several patterns of cross-reactivity to Class 5 
adhesins. In the panel of anti-dscCfaE MAbs, three MAbs (P1F9, P8010 and P4E6) are 
specific for CfaE (Fig. 4a), so their potential epitopes were confined to residues found 
exclusively in ME. Two MAbs (P6C1 I and P6114) showed cross-reactivity between CfaE and 
CsuD (Fig. 4b), so we focused on identical residues between both adhesins, but not shared in 
other adhesins. MAb P2E1 1 reacted to all adhesins in subclass 5a (Fig. 4c), suggesting for 
epitopes shared within the subclass. Reactivity across different subclasses was observed for 
two MAbs (P1OA7 and P5C7) that reacted to CfaE (subclass 5a) and CsbD, CooD (subclass 
5b) (Fig. 4d), showing that the potential epitopes are shared only by the mentioned adhesins. 
Two MAbs (P3B2 and P13A7) exhibited class-wide cross-reactivity to all tested Class 5 
adhesins (Fig. 4e). 
A total of nine anti-dscCsbD MAbs (P1F7, P2A9, P2H6, P5Al2, P6GI, P7C2, P7F12, 
P9A5 and P9D12) showed reactivity to only subclass 5b, and this pool of MAbs was further 
divided according to their functional activity (Fig. 5a,b). Anti-dscCsbD P9E1 1 that showed 
reactivity to CsbDad, reacted to all adhesins in subclasses 5a and 5b (Fig. 5c) but the reactivity 
to subclass 5a adhesins was much lower than reactivity to subclass 5b adhesins, indicating that 
this MAb targets common residues found in the adhesin domains in both subclasses. Anti-
dscCsbD MAb P7139 displayed high reactivity across all Class 5 adhesins (Fig. 5d). 
Anti-dscCotD MAbs were divided to three patterns of reactivity. Five of them (P7176, 
P3174, P6B8, P3D1 I and P2B8) reacted uniquely to CotD (Fig. 6a). MAb P12A2 showed 
cross-reactivity to CfaE and CsuD within subclass 56 (Fig. 6b), indicating that the epitopes are 
common only in these adhesins. The remaining two MAbs (P9A10 and P9G7) also displayed 
selected cross-reactivity within subclass 5a by showing reactivity to CsfD and CsuD, but not 
CfaE (Fig. 6c). None of anti .dscCotD MAbs reacted to subclass 5b adhesins. Consistent with 
each other, the dot blot and ELISA reactivity suggested the diversity of the anti-adhesin MAbs 
tested in this study. 
Epitope mapping of anti-adhesin MAbs based on multiple sequence alignment 
To examine the epitope mapping of the MAbs, we aligned the sequences from all six tested 
adhesins (CfaE, CsID, CsuD, CsbD, CooD and CotD) using BioEdit and ClustaiW programs. 
By referring to the MAb domain specificity and cross-reactivity patterns, we grouped identical 
and non-identical residues on heterologous adhesins and listed for potential epitopes of the 
MAbs (Table 3). 
Since anti-dscCfaE MAbs specific for adhesin domain recognized residues R67 and 
R18 1,  we could narrow down the list of potential epitopes by checking for residues positioned 
around the upper pole of the domain. However, due to insufficient number of allelic variants 
and mutant proteins available, we were unable to identify the most probable region of the 
epitopes for anti-dscCsbD and dscCotD MAbs localizing to either adhesin or pilin domain. 
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Figure 4 Cross-reactivity patterns of anti-dscCfaE MAbs. Bar graphs represent pattern of ELISA 
reactivity. The values indicated below graphs denote the lowest MAli concentration (Jig/ml) 
that effectively inhibited MRHA against ETEC strains harboring the respective adhesin 
proteins (CfaE: CFA/1 H10407; CsfD: CS4 BANG10-SP; CsuD: CS14 WS3294A; CsbD: CS17 
WS6788A; CooD: CS1 WS1974A; CotD: CS2 C91f). PBS serves as background value without 
antigen. (a) Two MAbs (P1F9 and P8D1) reacted to only CfaE and strongly inhibited MRHA 
against CFA/l. (b) MAbs P6C11 and P61 ­14 showed selective reactivity within subclass Sa (CfaE 
and CsuD), but not to CsfD. The MAbs strongly inhibited MRHA against only CFA/l. (c) MAb 
P2D1 reacted to all subclass Sa adhesins, but inhibited MRHA exclusively against CFA/1 
H10407. (ci) MAbs P1OA7 and P5C7 showed cross-reactivity to CfaE (subclass 5a) and to CsbD, 
Cool) (subclass Sb), and showed MRHA inhibition against CFA/t and C517. (e) MAbs P382 and 
P13A7 showed modest class-wide cross-reactivity and functionality.
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Figure 5 Cross-reactivity patterns of anti-dscCsbD MAbs. Bar graphs represent pattern of 
ELISA reactivity. The values indicated below graphs denote the lowest MAb concentration 
(ig/ml) that effectively inhibited MRHA against ETEC strains harboring the respective adhesin 
proteins (CfaE: CFA/1 H10407; CsfD: CS4 BANG10-SP; CsuD: CS14 WS3294A; CsbD: CS17 
WS6788A; Cool): CS1 WS1974A; CotD: CS2 C91f). PBS serves as background value without 
antigen. (a) Five MAbs (P7C2, P9A5, P21 ­16, P6G1 and P2A9) reacted to both CsbD and Cool) 
(subclass Sb) and strongly inhibited MRHA against both CS17 and CSL (b) Four MAbs (P1F7, 
P9012, P7F12 and PSAl2) also reacted to both CsbD and Cool) (subclass Sb), but did not 
inhibit MRHA against cSl at all. (c) MAb P9E11 reacted to CsbD, Cool) (subclass Sb), and 
adhesins in subclass 5a, but showed MRHA inhibition Only against CS17. (d) MAb P7F9 
showed strong cross-reactivity to adhesins in all subclasses, but did not show inhibition of 
MRHA against any ETEC strain.
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Figure 6 Cross-reactivity patterns of anti-dscCotD MAbs. Bar graphs represent pattern of 
ELISA reactivity. The values indicated below graphs denote the lowest MAb concentration 
(j.ig/ml) that effectively inhibited MRHA against ETEC strains harboring the respective adhesin 
proteins (CfaE: CFA/1 H10407; CsfD: C54 BANG10-SP CsuD: CS14 WS3294A; CsbD: CS17 
WS6788A; Cool): CS1 WS1974A; CotD: CS2 C91f). PBS serves as background value without 
antigen. (a) Five MAbs (p7F6; P3F4, P6B8, P3D11 and P2B8) reacted to only CotD and 
inhibited MRHA against CS2. (b)MAb P12A2 reacted to CfaE, CsuD (subclass Sa) and CotD 
(subclass Sc), and showed moderate MRHA inhibition against CS2. (c) Two MAbs (P9A1O and 
P9G7) showed cross-reactivity between CsfD, CsuD (subclass 5a) and CotD (subclass 5c), but 
showed very weak or lack of inhibition against CS2.
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Functional activity of anti-adhesin MAbs to wild type representative ETEC strains 
Six anti-dscCfaE MAbs (PIF9, P81310, P6C1 1, P6H4, P1OA7 and P5C7) inhibited MRFIA at 
similarly low MAb concentration against CFA/1 (Fig. 4a,b,d) although their cross-reactivity 
on ELISA differed. Interestingly, MAbs P1OA7 and P5C7 showed MRHA inhibition against 
CS 17 as well (Fig. 4d), suggesting that their epitopes are shared by CfaE and CsbD. Even 
though MAb P2E1 1 showed cross-reactivity within subclass 5a, it inhibited MRHA 
exclusively against CFAII at a moderate concentration (Fig. 4c, so this M,Ab may actually 
target several epitopes of MAbs P1 F9, P8131 0, P6C 11 and P6114. Despite the class-wide cross-
reactivity presented by MAbs P3B2 and P13A7, they did not show class-wide functionality. 
MAb P3B2 showed functional activity, against three ETEC strains (CFA/I, CS17 and CSI). On 
the other hand, MAb P13A7 inhibited MRHA against only CS17 (Fig. 4e), but not to CFA/I. 
From a total of nine anti-dcCsbD MAbs that showed reactivity limited to subclass 5b, 
five MAbs (P7C2, P9A5, P2A9, P601 and P2H6) induced strong MRHA inhibition against 
both CS17 and CSI strains (Fig. Sa). Two MAbs (PIF7 and P5Al2) exhibited weak inhibition 
against only CS17 (Fig. Sb). Meanwhile, MAbs P5Al2, P7F12 and P7F9 mutually showed 
non-functionality to any of the adhesins (Fig. 5b,d). When we examined closer, MAbs P1177 
and P9E1 1 actually demonstrated similarly low functional activity despite their different 
ELISA reactivity (Fig. 5b,c). 
For anti-dscCotD MAbs, four MAbs (F7F6, P3F4, P6B8 and P313 fl) that showed high 
reactivity to CotD and CotDad, strongly inhibited MRI-IA against CS2 at low MAb 
concentrations (0.5-16 pgIml) and this result correlated to the exclusive reactivity to CotD on 
ELISA (Fig. 6a). MAbs P2B8 and P907 that showed lack of reactivity to CotDad, displayed 
no functional activity to any of the adhesins, even though the MAbs showed rather strong 
reactivity to heterologous adhesins on ELISA (Fig. 6a,c). Meanwhile, MAbs P9AI0 and 
P12A2 showed weak inhibition of MRHA against CS2 (Fig. 6b,c). We could see that anti- 
dscCotD MAbs exhibited functional activity strictly exclusive to CS2 C91f which fimbriae 
were used to raise the MAbs, in spite of their different cross-reactivity patterns shown on 
ELISA. 
By evaluating MAb functionality against the allelic variants of wild type ETEC strains, 
we could identify more concrete epitopes involved in bacterial adhesion to erythrocytes. We 
tested three CS17 allelic strains (CS17 WS6788A, C517 WS4240A and CS17 LSN139) to 
induce MRI-IA (see Table 2). Functional activity of two anti-dscCfaE MAbs (P5C7 and 
P1OAI) and one anti-dscCsbD MM, (P2H6) was lost when tested against CS17 WS4240A, 
although the three MAbs showed effective MRHA inhibition against CS1 7 WS6788A (Fig. 4d, 
Sa). This result suggested that these MAbs recognized residue L85. This observation was 
supported by ELISA and dot blot data where MAb P2H6 reactivity to mutant protein 
dscCsbDJT84N-L85R was reduced to basal level (data not shown). 
To summarize, the MAb functionality based on HA! results varied and did not correlate 
to the cross-reactivity of the MAbs based on ELISA and dot blot. High reactivity to adhesins 
on ELISA did not indicate strong functional activity of the MAbs in inhibiting 
hemagglutination. Table 3 showed a summary for domain specificity and potential epitopes of 
the anti-adhesin MAbs.
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Table 3 Domain specificity and potential epitopes of the anti-adhesin MAbs. Epitopes 
determined by ELISA and dot blot reactivity were bolded, those inferred from sequence 
alignments (BioEdit and ClustaIW) were denoted in regular font, and those determined by 
functional activity were labeled by asterisk (*).
Adhesin MAbs MAb Epitope Potential epitopes 
binding conformation 
domain 
CfaE2 P5C7 CfaEad Conformational R67, 185*, R181, 1185 
P6C11 CfaEad Conformational N31, Y54, R67, 076, Al28, R145, R181, D184 
P6H4 aaEad Conformational N31, Y54,R67, Q76, Al28, R145, R181, D184 
P8D1O cfaEad Conformational •N26, H63, R67, 569, S85, D87, A88, N178, R181 
PICA7 CfäEad Conformational R67, L85*, R181, 1185 
P1F9 CfaEpd Conformational 5259, 1(268, 5274, V278, N289, 1(338, 1(350 
P2E11 CfaEpd Conformational Q210, 1(212, 1224, G226, T228,1230, R232, 5248, 
1(260, S261, D262, G263, K264, Y266, N271, D272, 
D273, E276, T280, L290, T291, T293, 1298, N299, 
A303, T316, Q332, D334, K336, M346, N348, 
0358,1359 
P3B2 CfaEpd Conformational 1198-0205, W207, P209, F211, S213, R216, D218-
1221, P223, G225, Y229, G231, N233, M237-C238, 
Y240-T245, 5247, 5249, F254-D256, 1267, 1(269, 
Y279, S282-1284, P292, N294, G295, 1300, 1305, 
E306, N308-11311, V315, P318, P323-P328, 1331, 
P340, A342, G343, Y345, 6347, T352S356, 1360 
P13A7 CfaEpd Linear 1198-0205, W207, P209, F211, S213, R216, D218-
1221, P223, (3225, '(229, G231, N233, M237-C238, 
Y240-1245, S247, S249, F254-D256, 1267, 1(269, 
Y279, S282-L284, P292, N294, G295, 1300, 1305, 
E306, N308-R311, V315, P318, P323-P328, 1331, 
P340, A342, G343, '(345, G347, 1352-S356, L360 
csbDb P17 CsbDad Conformational P22-V26, N28-R37, V42, 043, 151, L59,167, V68, 
172, S75, P77, V78, G86, 187, 689-Y92, 194, T96, 
Nih, 1112, •L114, A115, N117, K119-W122, Q125, 
S126, D128, S130, N131, 1132, V134, 1(138, 5141, 
G143, H144, G146, N147, N149, TiSi, 1152,  
N154,1176, L179, S180, N192 
P2A9 CsbDad Conformational P22-V26, N28-R37, V42, Q43, 151, L59,167, V68, 
172, S75, P77, V78, 686, 187, G89-Y92, 194, T96, 
Nih, 1112, 1114, AilS, N117, K119-W122, Q125, 
S126, D128, S130, N131, 1132, V134, 1(138, S141, 
G143, H144, (3146, N147, N149, 1151, 1152,  
N154,1176, 1179, S180, N192
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- P2H6 CsbDad Conformational P22-V26, N28-R37, V42, Q43, 151, 159, 167, V68, 
172, S75, P77, V78, 185, 686, T87, G89-Y92, T94, 
T96, Nih, 1112, L114, Ails, N117, K119-W122, 
Q125, S126, 0128, S130, N 131, 1132, V134, K138, 
S141, 6143, H144, 6146, N147, N149, T151, L152, 
N154,1176, L179, S180, N192 ______
 
P5Al2 CsbDad Conformational P22-V26, N28-R37, V42, Q43, T51, L59,167, V68, 
T72, S74,S75, P77, V78, 686, T87, G89-Y92, 194, 
196, 1107, Nih, 1112, L114, AilS, N117, 1(119-
W122, Q125, S126, D128, S130, N131, 1132, 
V134, 1(138, S141, G143, H144, Y145, G146, N147, 
N1491 T151, 1152, N154,1176, L179, S180, N192 
P6G1 CsbDad Conformational P22-V26, N28-R37, V42, Q43, T51, L59,167, V68, 
172, S75, P77, V78, G86, T87, G89-Y92, 194, T96, 
Nih, 1112, 1114, AilS, N117, K119-W122, 0125, 
5126, D128, S130, N131, 1132, V134, 1(138, S141, 
6143, H144, G146, N147, N149, 1151, L152,  
N154,1176, L179, S180, N192 
P7C2 csbDad Conformational P22-V26, N28-R37, V42, Q43, T51, L59,167, V68, 
172, S75, P77, W8, 686, T87, G89-Y92, T94, 196, 
Nih, 1112, 1114, AilS, N117, K119-W122, Q125, 
S126, D128, 5130, N131, 1132, V134, 1(138, 5141, 
6143, H144, G146, N147, N149, T151, 1152,  
N154,1176, 1179, S180, N192 
P7F9 CsbDad linear G27, D39, R40, P45,149, '(57, H61, 163, 065, R66, 
F69, C71, 573, S74, G80-P83, 693, T95, 197, L99, 
F101-K104, S106, L107, G116, 1(118, C127, 1135-
5137, G149, 1154-P157, G159, €160, 1164, G167, 
6168, W170, A172, 1174, L176, R181, G191, Y193, 
N196-T198 
P9A5 CsbDad Conformational P22-V26, N28-1137, V42, Q43, 151, L59,167, V68, 
172, 575, P77, V78, G86, T87, G89-Y92, T94, 196, 
Nih, 1112, 1114, AilS, N117, K119-W122, Q125, 
S126, 0128, S130, N131, 1132, V134, 1(138, S141, 
6143, H144, 6146, N147, N149, 1151, 1152,  
N154,1176, L179,  S180, N192 
P9E11 CsbDad Conformational S74, [85, T87, 1107, H144, '(145 
P7F12 CsbDpd Linear 6213, Y230, M253, V254, 1(256, 1263, 5265, S266, 
'(270, 6275, E277, K278, A282, V283, M287-E289, 
1291, V295, S299, S305-V307, V315, A319, V323-
N324, L335, N337, P339, A342, 0344, Q351, '(353, 
V360-N362 
P9012 CsbDpd linear G213, Y230, M253, V254, 1(256, 1263, S265, 5266, 
'(270, 6275, E277, 1(278, A282, V283, M287-E289, 
1291, V295, S299, S305-V307, V315, A319, V323-
N324, 1335, N337, P339, A342, D344, Q351, Y353, 
V360-N362
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Figure 7 ELISA reactivity of 
CfaE peptides within adhesin 
domain. The numbers labeled 
on x-axis represent CfaE 
peptides 1-34. Peptides 8-13 
(region 1), peptides 18-23 
(region 2) and peptides 30-34 
(region 3) showed high 
reactivity to anti-dscCfaE MAb 
P6C11.
COtDC P3D11 CotDad Conformational A45, Y51, 063, F67, D78, 1(82, T87, KiOl, 1103, 
1(108, A111-K113, 1151, F156, 0162, 1168, 1169, 
1173, H190, 1(194 
P3F4 CotDad Conformational A45, '(51, D63, F67, 078, K82, 187, 1(101, 1103, 
K108, A111-K113, 1151, F156, 0162, 1168, L169, 
1173, H190, K194 
136138 CotDad Conformational A45, '(51, D63, F67, D78, 1(82, 187, 1(101, 1103, 
1(108, A111-K113, 1151, F156, Q162, 1168, 1169, 
1173, H190, K194 
P7F6 CotDad Conformational A45, '(51, 063, 167, 078, 1(82, 187, 1(101, 1103, 
1(108, A111-K113, T151, F156, 0162, L168, 1169, 
1173, 1-1190, K194 
P9A1O CotDad Linear Y50, S87, D89, S91, V173, T177, R181 
P288 CotDpd Linear 1211, 1220, V237, E239, 1242 1 H249, S261, R291, 
1(317, S318, 1321, 0232, N334, F337, S339, 1341, 
€348, L353 
P9G7 CotDpd Linear 0218, N354 
P12A2 CotDpd I Linear N31, D187, V199
a Residues listed as potential epitopes were referred to those found in referent CFA/I H10407. 
b Residues listed as potential epitopes were referred to those found in referent CS17 WS6788A. 
C Residues listed as potential epitopes were referred to those found in referent CS2 C91f. 
MAb reactivity to CfaE peptides 
We tested reactivity of 71 CfaE peptides using anti-dscCfaE MAb P6C1 I on ELISA. Given 
that P6C1 1 is a CfaEad-specific MAb, we focused on peptides only within the adhesin domain 
(ME peptides 1-34). We observed three regions of overlapping CfaE peptides located in 
adhesin domain showing considerable 0D450 signals (Fig. 7). Based on amino acid sequences, 
these regions consist of positively charged amino acids (i.e. arginine and lysine) that may have 
reacted to the MAb. interestingly, regions 1 and 3 contained two critical residues R67 and 
R18 1,  respectively. These results are consistent with findings using EL1SA and dot blot. 
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DISCUSSION 
In this study, we examined the epitope mapping of anti-adhesin MAbs specific for ME, CsbD 
and CotD, the adhesin subunits of CFA/l, CSI7 and CS2 ETEC fimbriae. By combining 
analysis of reactivity of a panel of Class 5 adhesins on dot blot and ELISA with multiple 
sequence alignments of the protein sequences, the potential epitopes of the MAbs were sorted 
by the domain specificity and the potential epitopes were identified. The functional activity of 
the MAbs was evaluated in HAl assay and correlated back to its cross-reactivity on ELISA. 
We tested the MAb reactivity against natural allelic variants and adhesin mutants carrying 
specific modified residues located around the receptor-binding pocket, that are likely to 
participate in cell adhesion. In order to expand the existing collection of Class 5 adhesin 
proteins and mutants at NMRC, we overexpressed and purified three dscCfaE allelic variant 
proteins (dscCfaEiT91I, dseCfaE/Al28V and dscCfaE/Q142V), each containing one residue 
difference from referent strain CFA/i H10407. Given that the modification site in each variant 
being nearby the ligand-binding pocket of C-M, we anticipated to see the role of the three 
residues in affecting cell adhesion. During purification by cation-exchange chromatography, 
dscCfaE/Q142R was eluted at higher salt gradient than dscCfáEiT9ii and dscCfaE/Al28V 
because change from glutamine (uncharged) to arginine (positively charged) in 
dscCfaE/Q142R provides extra positive charge on the protein, which subsequently binds 
stronger to the column and requires higher salt concentration to elute out. When we tested 
MRHA activity of the dscCfaE variants, modification of T911 was shown to demolish ability of 
dscCfaE to bind erythrocytes, suggesting that residue T91 plays an active role in bacterial 
adhesion. Our-finding seems to contradict the notion that CfaE attained 1911 under positive 
selection to enhance functional binding to host cells 7 . 
In defining the epitope mapping of the anti-adhesin MAbs, we divided the three panels of 
MAb into adhesin domain-specific or pilin domain-specific. The domain specificity is crucial 
to identify the epitope regions around the adhesin proteins. Five anti-dscCfaE MAbs include 
R67 and R181. that are located in the receptor-binding pocket of CfaE, suggesting that these 
MAbs consist of immunodominant conformational epitope and bind to the upper pole of CfaE. 
Three anti-dscCsbD MAbs recognize L85, H144 or R181 that are positioned at the upper pole 
of CsbD. As for the remaining anti-dscCsbD MAbs and all anti-dscCotD MAbs, we were 
unable to specify the binding regions on the adhesins, whether the epitopes are clustered 
around or dispersed away from the upper pole. In this case, use of sequence alignments to 
obtain the potential epitopes is very useful to group the MAts that target similar epitopes. 
Perhaps, molecular visualization of the adhesins and the position of the epitopes using three-
dimensional structural analysis program would be a practical approach to solidify the epitope 
regions'3. 
We observed the variability of reactivity and functionality of the MAbs in this study. 
There are two important aspects to explain the relationship between cross-reactivity and 
functional activity of the MAbs. Firstly, although the cross-reactivity patterns may have 
suggested that the anti-adhesin MAbs share the same epitopes across the Class 5 adhesins, but 
the epitopes do not appear to contribute in bacterial adhesion. For example, two anti-dscCfaE 
MAbs (P3B2 and P13A7) and one anti-dscCsbD MAb (P7F9) showed class-wide reactivity to 
all adhesins in subclasses 5a, 5b and Sc, but did not show class-wide inhibition of MRHA. This 
finding indicates that there are conserved epitopes across Class 5 adhesins but they do not 
participate in receptor binding. Secondly, the structure of each adhesin in Class 5 fimbriae, 
especially the receptor-binding domain, may not be identical. Changes of residues in the 
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homologous and heterologous adhesins also alter the surface contours and polarity of the 
proteins13 . The sequence alignments reveal that the Class 5 adhesins possess different length of 
loops and even contain gaps between residues, further adding to the distinctions between their 
molecular structures. Monoclonal antibodies are very specific in binding to their target 
epitopes. Any subtle change of epitopes involved in the receptor binding domains of the 
adhesins will dramatically reduce the reactivity, and further abolish the functional activity 
against heterologous ETEC strains. It is also possible that our MAb collection is inadequate in 
number, which is another reason that we could not identify any MAb showing class-wide 
functionality. 
Conformational change is not only caused by residue changes, but also by the MAb 
interaction with the protein. A recent study reported that antibodies specific for Fimil, the 
Type I fimbrial adhesin subunit expressed in E. coli in urinary tract infections, enhances 
bacterial adhesion to urothelial cells instead of inhibiting the pathogen 14 . The MAbs bind to 
lectin domain positioned away from binding pocket, converting the domain's conformation 
from low- to high-affinity state, and promote attachment of Fimil to its ligands' 4. From our 
results, three anti-adhesin MAbs implied that their binding might have changed the protein 
conformation. Anti-dscCfaE MAbs P382 and P1F9 seemed to bind to pilin domain of CfaE, 
but exhibited strong inhibitory activity against CFA/I H10407. Anti-dscCsbD 1`91312 is also 
assumed to bind to pilin domain of CsbD but inhibited MRHA at low MAn concentration 
against CS 17 WS6788A. It is possible that these MAbs bind to a region distal to the ligand-
binding pocket, further twisting and locking the adhesins into a conformation that is less 
accessible for attachment. These MAbs should be investigated further in order to define their 
epitope regions and to better understand their mechanism in inhibiting bacterial adherence to 
cells.
Aside from testing MAb reactivity against protein antigens, we intended to apply 
overlapping peptide library to narrow down epitope regions of the MAbs. It has been reported 
that peptide EL1SA containing amino acid sequences of highly conserved and antigenic epitope 
is effective to detect antibodies specific to human H5N1 influenza viruses 15 . This method 
offers the capacity to identify the most probable regions where MAbs would bind on the 
proteins. Although the peptides are linear, they still contain partial epitopes that are detectable 
by the MAbs. Interestingly, anti-dscCfaE MAb P6C1 I used to test the reactivity actually 
recognizes conformational epitope better than denatured, linear epitopes, but it is still able to 
elicit reactivity of CfaE peptides. The three regions of CfaE peptides that showed reactivity on 
ELISA contained a number of positively charged amino acids (i.e. arginine and lysine), 
including R67 and R181, each in separate region. The strongly charged amino acids could' 
affect ligand binding of the peptides. Based on our results so far, we have yet to reach a 
definitive analysis on which peptides essentially hold the residues that will fold into actual 
epitope in the protein's native conformation. Nonetheless, using peptide library approach in 
epitope mapping is encouraging to generate interesting data. Further test involving CfaE 
peptide library is ongoing. 
Development of vaccine against pathogenic bacteria has been a long battle considering 
the antigenic variability of the bacterial proteins. Scientists have been attempting to find a 
common antigen that induces broad protective immunity. Recently, a chimeric antigen with an 
engineered surface containing specificities to three major variant groups of factor Fl binding 
protein (tHI3P), the protective antigen of Neisseria mehingitidis, was shown to induce cross- 
protective immunity against different fHBP alleles in meningococcal strains tested16. 
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The rational design approach based on antigen structure is promising to create broadly 
protective vaccines. Our findings could be elaborated into determining the structural design of 
adhesin proteins possessing epitopes for different MAbs, and further incorporating multiple 
epitopes on one functional, antigenic molecule. 
In summary, we managed to determine domain specificity of three groups of anti-adhesin 
MAbs, qualitatively measured the functional activity of each MAb against ETEC strains, and 
verified several epitopes for at least seven MAbs. This project had been heavily focused on 
characterizing the collection of anti-adhesin MAbs available on our hands, and understanding 
the concept of unique and common epitopes shared among these MAbs. We hope that our 
findings will be beneficial for upcoming studiesrelated to ETEC Class 5 fimbriae. 
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